FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Atenolol Tablets
Status: Currently in Shortage
»Date first posted: 07/26/2017
»Therapeutic Categories: Cardiovascular

Expand all

Mylan Pharmaceuticals Inc. (Reverified 08/15/2017)

Company Contact Information:
877-446-3679 (1-877-4-INFO-RX)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25mg (NDCs 0378-0218-01 and 0378-0218-10) Limited Supply, expected re-supply date TBD. Shortage of active ingredient
50mg (NDCs 0378-0231-01 and 0378-0231-10) Limited Supply, expected re-supply date TBD. Shortage of active ingredient
100mg (NDCs 0378-0757-10 and 0378-0757-01) Limited Supply, expected re-supply date TBD. Shortage of active ingredient

Sandoz (Reverified 08/15/2017)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg 100 count bottle (NDC 0781-1078-01) Anticipated resupply and inventory recovery TBD Shortage of an active ingredient
25 mg 1000 count bottle (NDC 0781-1078-10) Anticipated resupply and inventory recovery TBD Shortage of an active ingredient
50 mg 100 count bottle (NDC 0781-1506-01) Anticipated resupply and inventory recovery TBD Shortage of an active ingredient
50 mg 1000 count bottle (NDC 0781-1506-10) Anticipated resupply and inventory recovery TBD Shortage of an active ingredient
100 mg 100 count bottle (NDC 0781-1507-01) Anticipated resupply and inventory recovery TBD Shortage of an active ingredient
100 mg 1000 count bottle (NDC 0781-1507-10) Anticipated resupply and inventory recovery TBD Shortage of an active ingredient

Teva Pharmaceuticals (Revised 08/16/2017)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg 100 (NDC 0093-0752-01) Teva has limited inventory and product is being allocated. Supply on allocation will be in effect until late Q4-2017 Shortage of an active ingredient
100 mg 100 (NDC 0093-0753-01) Teva has limited inventory and product is being allocated. Supply on allocation will be in effect until late Q4-2017 Shortage of an active ingredient
100 mg 500 (NDC 0093-0753-05) Teva has limited inventory and product is being allocated. Supply on allocation will be in effect until late Q4-2017 Shortage of an active ingredient
25 mg 100 (NDC 0093-0787-10) Teva has limited inventory and product is being allocated. Supply on allocation will be in effect until late Q4-2017 Shortage of an active ingredient
25 mg 1000 (NDC 0093-0787-10) Teva has limited inventory and product is being allocated. Supply on allocation will be in effect until late Q4-2017 Shortage of an active ingredient
50 mg 1000 (NDC 0093-0752-10) Teva has limited inventory and product is being allocated. Supply on allocation will be in effect until late Q4-2017 Shortage of an active ingredient

Zydus Pharmaceuticals USA Inc. (New 07/26/2017)

Company Contact Information:
877-993-8779

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Atenolol Tablets, USP, 25mg, 100s (NDC 68382-022-01) Available Zydus is able to supply its current customer demand and has increased capacity to support additional demand starting in August. Increased demand
Atenolol Tablets, USP, 25mg, 1000s (NDC 68382-022-10) Available Zydus is able to supply its current customer demand and has increased capacity to support additional demand starting in August. Increased demand
Atenolol Tablets, USP, 50mg, 100s (NDC 68382-023-01) Available Zydus is able to supply its current customer demand and has increased capacity to support additional demand starting in August. Increased demand
Atenolol Tablets, USP, 50mg, 1000s (NDC 68382-023-10) Available Zydus is able to supply its current customer demand and has increased capacity to support additional demand starting in August. Increased demand
Atenolol Tablets, USP, 100mg, 100s (NDC 68382-024-01) Available Zydus is able to supply its current customer demand and has increased capacity to support additional demand starting in August. Increased demand
Atenolol Tablets, USP, 100mg, 1000s (NDC 68382-024-10) Available Zydus is able to supply its current customer demand and has increased capacity to support additional demand starting in August. Increased demand

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English